Downloads provided by UsageCounts
This is Neelika Malavige’s presentation at the monthly [virtual] Antiviral Drug Discovery (AViDD) Open Science Forum on 2022 December 21. Their talk centers the epidemiological, clinical and immunological risk factors of severe dengue. You can find a recording of their talk on the AViDD Open Science Forum Youtube page. Neelika Malavige is the Head of Dengue Global Programme and Scientific Affairs, India at DNDi (Drugs for Neglected Disease Initiative).
Antiviral Drug Discovery, AViDD, Open Science Forum, open science, Antiviral Drug Discovery Open Science Forum, AViDD Open Science Forum
Antiviral Drug Discovery, AViDD, Open Science Forum, open science, Antiviral Drug Discovery Open Science Forum, AViDD Open Science Forum
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 7 | |
| downloads | 7 |

Views provided by UsageCounts
Downloads provided by UsageCounts